Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment
Dual Diagnosis Psychosis and Substance Abuse: Short- and Middle-term Changes in Symptomatology After Visiting a Group Education Programme to Reduce Consumption of Cannabis
1 other identifier
interventional
50
1 country
1
Brief Summary
Intention of the study is to examine, if the symptomatology of dual diagnosis patients is less severe after a special indication training for reduction of cannabis consumption in comparison to unspecified trainings. Point of interest is psychopathology and consumerism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Jan 2006
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedFirst Submitted
Initial submission to the registry
October 30, 2008
CompletedFirst Posted
Study publicly available on registry
October 31, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2010
CompletedJanuary 12, 2010
October 1, 2008
3.4 years
October 30, 2008
January 11, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PANSS Positive and Negative Symptom Scale
post intervention, six months follow-up
Secondary Outcomes (1)
Urinstatus for cannabinoids
weekly during and post intervention, follow-up
Study Arms (2)
ACT
EXPERIMENTALAnti-Cannabis-Consumption-Training
CG
ACTIVE COMPARATORControl group
Interventions
8 sessions within 4 weeks (twice a week, 45 minutes each) Cognitive behavioral therapy with focus on cannabis abuse
8 sessions within 4 weeks (twice a week, 45 minutes) training to develop and ameliorate social competences
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of schizophrenia and disorders with psychotic features
- Misuse of cannabis during 12 months preceding admission to hospital
You may not qualify if:
- Not able to attend training twice a week for 45 minutes (concentration, attention, psychotic symptoms, agitation)
- Discharge from hospital before completion of training
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Konstanz
Konstanz, Baden-Wurttemberg, 78462, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hans Watzl, Dr.
University of Konstanz
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 30, 2008
First Posted
October 31, 2008
Study Start
January 1, 2006
Primary Completion
June 1, 2009
Study Completion
January 1, 2010
Last Updated
January 12, 2010
Record last verified: 2008-10